Ceramide accumulation during oxidant renal tubular injury: Mechanisms and potential consequences

Journal of the American Society of Nephrology

Volumn 9, Issue 9, 1998, Pages 1670-1680

  Zager, Richard A ^a,b   Conrad, D Scott ^a   Burkhart, Kristin ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 QUINOLINOL; ACYLSPHINGOSINE DEACYLASE; ARACHIDONIC ACID; CERAMIDE; FUMONISIN B1; GLUTATHIONE; IRON; OXIDIZING AGENT; PHOSPHOLIPASE A2; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; SPHINGOSINE ACYLTRANSFERASE;

ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DAMAGE; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0031781921     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Mattys E, Patel Y, Kreisberg J, Stewart JH, Venkatachalam MA: Lipid alterations induced by renal ischemia: Pathogenic factor in membrane damage. Kidney Int 26: 153-161, 1984
2. Zhang Y, Kolesnick R: Signaling through the sphingomyelin pathway. Endocrinology 136: 4157-4160, 1995
3. Hannun Y: The sphingomyelin cycle and second messenger function of ceramide. J Biol Chem 269: 3125-3128, 1994
4. Testi R: Sphingomyelin breakdown and cell fate. Trends Biochem Sci 21: 468-471, 1996
5. Hannun YA: Functions of ceramide in coordinating cellular responses to stress. Science 274: 1855-1859, 1996
6. Obeid LM, Hannun YA: Ceramide: A stress signal and mediator of growth suppression and apoptosis. J Cell Biochem 58: 191-198, 1995
7. Mathias S, Kolesnick R: Ceramide: A novel second messenger. Adv Lipid Res 25: 65-90, 1993
8. Kim MY, Linardic C, Obeid L, Hannun YA: Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon: Specific role in cell differentiation. J Biol Chem 266: 484-489, 1991
9. 2 production and sphingomyelin metabolism: Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J Biol Chem 267: 20044-20050, 1992
10. Cuvillier O, Pirianov G, Kleuser B, Vanek PG, Coso OA, Gutkind S, Spiegel S: Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381: 800-803, 1996
11. Spiegel S, Merrill AH Jr: Sphingolipid metabolism and cell growth regulation. FASEB J 10: 1388-1397, 1996
12. Zager RA, Conrad S, Lochhead K, Sweeney EA, Igarashi Y, Burkhart KM: Altered sphingomyelinase and ceramide expression in the setting of ischemic and nephrotoxic acute renal failure. Kidney Int 53: 573-582, 1998
13. Iwata M, Herrington J, Zager RA: Sphingosine: A mediator of acute renal tubular injury and subsequent cytoresistance. Proc Natl Acad Sci USA 92: 8970-8974, 1995
14. Zager RA, Iwata M, Conrad DS, Burkhart KM, Igarashi Y: Altered ceramide and sphingosine expression during the induction phase of ischemic acute renal failure. Kidney Int 52: 60-70, 1997
15. 1 cells [Abstract]. J Am Soc Nephrol 8: 418A, 1997
16. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R: Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals. Cell 82: 405-414, 1995
17. Nath KA, Balla G, Vercellotti GN, Balla J, Jacob HS, Levitt MD, Rosenberg ME: Induction of heme oxygenase is a rapid and protective response in rhabdomyolysis in the rat. J Clin Invest 90: 267-270, 1992
18. Nath KA, Croatt AJ, Likely S, Behrens TW, Warden D: Renal oxidant injury and oxidant response induced by mercury. Kidney Int 50: 1032-1043, 1996
19. Agarwal A, Balla J, Alam J, Croatt AJ, Nath KA: Induction of heme oxygenase in toxic renal injury: A protective role in cisplatin nephrotoxicity in the rat. Kidney Int 48: 1297-1307, 1995
20. Paller MS, Jacob HS: Cytochrome p-450 mediates tissue-damaging hydroxyl radical formation during reoxygenation of the kidney. Proc Natl Acad Sci USA 91: 7002-7006, 1994
21. Baliga R, Zhang Z, Baliga M, Shah SV: Evidence for cytochrome p-450 as a source of catalytic iron in myoglobinuric acute renal failure. Kidney Int 49: 362-369, 1996
22. Ueda N, Guidet B, Shah SV: Gentamicin induced mobilization of iron from renal cortical mitochondria. Am J Physiol 265: F435-F439, 1993
23. Baliga R, Ueda N, Shah SV: Kidney iron status in passive Heymann nephritis and the effect of an iron-deficient diet. J Am Soc Nephrol 7: 1183-1188, 1996
24. Ryan MJ, Johnson G, Kirk J, Fuerstenberg SM, Zager RA, Torok-Storb B: HK-2: An immortalized proximal tubule epithelial cell line from normal human kidney. Kidney Int 45: 48-57, 1994
25. Sogabe K, Roeser NF, Venkatachalam MA, Weinberg JM: Differential cytoprotection by glycine against oxidant damage to proximal tubule cells. Kidney Int 50: 845-865, 1996
26. Younes A, Kahn DW, Besterman JM, Bittman R, Byun H-S, Kolesnick RN: Ceramide is a competitive inhibitor of diacylglycerokinase in vitro and in intact human leukemia (HL-60) cells. J Biol Chem 267: 842-847, 1992
27. Van Veldhoven PP, Mannaerts GP: Inorganic and organic phosphate measurements in the nanomolar range. Anal Biochem 161: 45-48, 1987
28. Merrill JH Jr, Wang E, Mullins RE, Jamison WCL, Nimkar S, Liotta DC: Quantitation of free sphingosine in liver by high performance liquid chromatography. Anal Biochem 171: 373-381, 1988
29. Quintern LE, Sandhoff K: Human acid sphingomyelinase from human urine. Methods Enzymol 197: 536-540, 1991
30. Chatterjee S, Ghosh N: Purification of neutral sphingomyelinase from human urine. Methods Enzymol 197: 540-547, 1991
31. Liu B, Hannun YA: Inhibition of neutral magnesium-dependent sphingomyelinase by glutathione. J Biol Chem 272: 16281-16287, 1997
32. Abul-Ezz SR, Shah SV: Role of glutathione in an animal model of myoglobinuric acute renal failure. Proc Natl Acad Sci USA 88: 9833-9837, 1991
33. Jayadev S, Linardic CM, Hannun YA: Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor α. J Biol Chem 269: 5757-5763, 1994
34. 2 regulate type I deiodinase expression in FRTL-5 cells. Thyroid 7: 647-654, 1997
35. Balsinde J, Balboa MA, Dennis EA: Inflammatory activation of arachidonic acid signaling in murine P388D1 macrophages via sphingomyelin synthesis. J Biol Chem 272: 20373-20377, 1997
36. Robinson BS, Hii CS, Poulos A, Ferrante A: Activation of neutral sphingomyelinase in human neutrophils by polyunsaturated fatty acids. Immunology 91: 274-280, 1997
37. Duane PG, Rice KL, Charboneau DE, King MB, Gilboe DP, Niewoehner DE: Relationship of oxidant-mediated cytotoxicity to phospholipid metabolism in endothelial cells. Am J Respir Cell Mol Biol 4: 408-416, 1991
38. 2 in cell damage. Arch Biochem Biophys 301: 119-128, 1993
39. Ungemach FR: Pathobiological mechanisms of hepatocellular damage following lipid peroxidation [Review]. Chem Phys Lipids 45: 171-205, 1987
40. Shaw S, Naegeli P, Etter JD, Weidmann P: Role of intracellular signalling pathways in hydrogen peroxide-induced injury to rat glomerular mesangial cells. Clin Exp Pharmacol Physiol 22: 924-933, 1995
41. Zhang JR, Scherch HM, Hall ED: Direct measurement of lipid peroxides in iron-dependent spinal neuronal injury. J Neurochem 66: 355-361, 1996
42. Zager RA, Iwata M: Inorganic fluoride: Divergent effects on human proximal tubular cell viability. Am J Pathol 150: 735-745, 1997
43. Sugita M, Dulaney JT, Moser HW: Ceramidase deficiency in Farber's disease (lipogranulomatosis). Science 175: 1100-1102, 1972
44. Zager RA, Conrad DS: Deferoxamine confers striking protection against cold storage injury to isolated mouse proximal tubules. Kidney Int 50: 2109-2111, 1996
45. Halliwell B, Gutteridge JMC: Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol 186: 1-85, 1990
46. Zager RA: Rhabdomyolysis and myohemoglobinuric acute renal failure [Editorial review]. Kidney Int 49: 314-326, 1996